People

George McBride

London, England, United Kingdom

Clerkenwell Health

Entruempelung koblenz

Debra Redman

Espen Einn

Zürich, Switzerland • Oslo, Norway • Trondheim, Norway • Alicante, Spain • Gothenburg, Sweden

Lyla Marquez

Hawaii, USA • Los Angeles, California, USA

H Graf

Rediscovering psilocybin as an antidepressive treatment strategy

C Timmermann

Increased global integration in the brain after psilocybin therapy for depression

JD Sexton

Increased global integration in the brain after psilocybin therapy for depression

RE Daws

Increased global integration in the brain after psilocybin therapy for depression

JM Mitchell

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

LJ Williams

Fisher's least significant difference (LSD) test

D Cremers

LSD-SLAM: Large-scale direct monocular SLAM

T Schöps

LSD-SLAM: Large-scale direct monocular SLAM

H Abdi

Fisher's least significant difference (LSD) test

J Engel

LSD-SLAM: Large-scale direct monocular SLAM

ECHM Haijen

Predicting responses to psychedelics: a prospective study

R Mechoulam

The pharmacohistory of Cannabis sativa

JM Morel

LSD: A fast line segment detector with a false detection control • LSD: A line segment detector

RG Von Gioi

LSD: A fast line segment detector with a false detection control • LSD: A line segment detector

MS Mercier

Ketamine and phencyclidine: the good, the bad and the unexpected

Adam Garfinkle

San Diego, California, USA

Greg Mayes

New Jersey, USA

Reunion Neuroscience

Chad Harman

Texas, USA

Psycheceutical

Magda Kurzawska

Tom McDonald

London, England, United Kingdom